AMEX · GDOC · USD
Stock price, dividends
Quote as of Oct 30, 2026, 08:00 PM UTC. Cached market data; not a live quote.
One-year closing-price history · USD. Historical prices are not a forecast.
Goldman Sachs Future Health Care Equity ETF’s quoted price sits in the upper half of its reported 52-week range, 0.0% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
THE INCOME SIDE
Goldman Sachs Future Health Care Equity ETF’s forward annual dividend is $0.11 per share, paid annual. The forward yield is 0.29% at the quoted price. Future payments can change.
Historical amounts are adjusted for stock splits. Understand ex-dividend and payment dates →
THE COMPANY BEHIND THE TICKER
The Goldman Sachs Future Health Care Equity ETF (the “Fund”) seeks long-term growth of capital. The fund invests in innovators and disruptors in the healthcare sector by looking for companies that are developing new treatments and technologies, primarily in genomics, precision medicine, tech-enabled procedures, and digital healthcare.
Latest available per-share figures in USD. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 31, 2026, 07:19 PM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
Completed calendar years and any current-year payments shown separately. Current-year totals are incomplete until all payments are made.
See annual income at the current dividend rate.
Assumes the annual dividend stays unchanged. Payments follow the company’s schedule. Excludes taxes, fees and currency changes.
KEEP COMPARING
$33.99-$0.46 (-1.34%)
Pacer US Small Cap Cash Cows Growth Leaders ETF’s quoted price sits in the upper half of its reported 52-week range, 2.21% below the high.
$26.56-$0.07 (-0.26%)
Principal Real Estate Active Opportunities ETF’s quoted price sits in the upper half of its reported 52-week range, 7.07% below the high.
$31.10$0.00 (0.0%)
Strive International Developed Markets ETF’s quoted price sits in the upper half of its reported 52-week range, 9.0% below the high.
$35.20-$0.09 (-0.24%)
Harbor Health Care ETF (MEDI)’s quoted price sits in the upper half of its reported 52-week range, 1.55% below the high.
$29.74+$0.39 (+1.33%)
Strive Mid-Cap ETF’s quoted price sits in the upper half of its reported 52-week range, 8.86% below the high.
$37.09-$0.51 (-1.36%)
Innovator U.S. Equity Accelerated Plus ETF’s quoted price sits in the upper half of its reported 52-week range, 1.98% below the high.
$39.03-$0.68 (-1.71%)
Wedbush Laffer Tengler New Era Value ETF’s quoted price sits in the upper half of its reported 52-week range, 7.22% below the high.
$47.75$0.00 (0.0%)
TrueShares Structured Outcome (November) ETF’s quoted price sits in the upper half of its reported 52-week range, 1.41% below the high.
